Ronald B. Moss's most recent trade in DMK Pharmaceuticals Corp was a trade of 8,199 Common Stock done at an average price of $0.6 . Disclosure was reported to the exchange on March 18, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| DMK Pharmaceuticals Corp | Ronald B. Moss | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 0.60 per share. | 18 Mar 2022 | 8,199 | 201,911 (0%) | 0% | 0.6 | 4,949 | Common Stock |
| DMK Pharmaceuticals Corp | Ronald B. Moss | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2021 | 13,911 | 0 | - | - | Restricted Stock Units | |
| DMK Pharmaceuticals Corp | Ronald B. Moss | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2021 | 13,911 | 245,663 (0%) | 0% | - | Common Stock | |
| DMK Pharmaceuticals Corp | Ronald B. Moss | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 0.41 per share. | 18 Nov 2020 | 8,532 | 231,752 (0%) | 0% | 0.4 | 3,465 | Common Stock |